NCT05954416 2026-02-12
FARD
Institut National de la Santé Et de la Recherche Médicale, France
Recruiting
Clinical Trials
15 trialsNCT07272616 2026-01-30
GDW
Region Stockholm
Recruiting
NCT06898684 2025-12-16
MOVE
Vastra Gotaland Region
Phase NA Recruiting
NCT07264569 2025-12-04
Evaluate the Safety, Tolerability, Biodistribution Characteristics and Preliminary Efficacy of BioTTT001
Henan Cancer Hospital
Phase 1/2 Recruiting
NCT07224451 2025-11-04
BDF002
Sheba Medical Center
Phase NA Recruiting
NCT04324450 2025-09-04
IMPALA
Institut National de la Santé Et de la Recherche Médicale, France
Phase NA Completed
NCT02656407 2025-09-02
FUSIMAGINE
Institut National de la Santé Et de la Recherche Médicale, France
Phase NA Completed
NCT07100600 2025-08-11
Trastuzumab Rezetecan Combined With Radiotherapy Versus Trastuzumab Rezetecan in the Treatment of HER2-positive Advanced Breast Cancer With Brain Metastases
Henan Cancer Hospital
Phase 2 Recruiting
NCT04610229 2025-06-12
GLIORAD
Azienda USL Reggio Emilia - IRCCS
Phase NA Completed
NCT05474573 2025-05-16
CONFLUENSE
Sklifosovsky Institute of Emergency Care
Phase NA Recruiting
NCT05475522 2025-05-16
SONOFLUO
Sklifosovsky Institute of Emergency Care
Phase NA Suspended
NCT05477680 2025-05-16
BRASH
Sklifosovsky Institute of Emergency Care
Phase NA Recruiting
NCT05484219 2025-05-16
FUN
Sklifosovsky Institute of Emergency Care
Phase NA Suspended
NCT05485038 2025-05-16
GAMMA
Sklifosovsky Institute of Emergency Care
Phase NA Suspended
NCT06971406 2025-05-14
FLAME-1
Henan Cancer Hospital
Phase 2 Not yet recruiting